We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





US Labs Increase COVID-19 Testing Capacity but Facing Shortage of Supplies, Finds NILA Survey

By LabMedica International staff writers
Posted on 06 Oct 2020
Print article
Illustration
Illustration
A survey of community and regional laboratories in the US has revealed a potential collective increase in COVID-19 testing capacity, although difficulties persist in accessing the necessary testing supplies.

The National Independent Laboratory Association (NILA St. Louis, MO, USA) conducted a survey of 12 twelve community and regional laboratories that revealed shortages of test kits, reagents, and other materials, such as plastic pipette tips, without which they were unable to perform the promised number of tests. In spite of an increase in their COVID-19 testing capacity, these labs do not have access to the supplies and materials necessary to perform critical COVID-19 tests. For example, one regional laboratory reported an allocation from a manufacturer of enough reagents to process 500 tests per day, although it has a capacity for performing at least 3,000 tests per day.

The NILA has stressed that speedy test results are critical for isolating infected patients and mitigating the spread of COVID-19. Community and regional laboratories report they can provide test results within one to two days which is significantly faster than the reported wait times experienced by most of the US population in recent weeks and months. According to the NILA, mitigating supply shortages will help increase the number of tests provided as well as the speed with which test results are delivered.

“The federal government must do whatever it can to help alleviate the testing supply shortages NILA members are experiencing,” said Mark Birenbaum, Ph.D., executive director, NILA. “We won’t emerge from this pandemic unless we focus on testing, and community and regional independent laboratories are key to scaling up our nation’s testing capacity. We have not seen transparency from the federal government regarding where test supplies are being allocated and how community labs can increase their access to these essential supplies.”

Related Links:
National Independent Laboratory Association

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.